日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individuals from the cvMOBIUS2 registry

在患有动脉粥样硬化性心血管疾病和 2 型糖尿病的极高危患者中,达到基于指南的血脂目标的情况:来自 cvMOBIUS2 注册研究的 213,380 名受试者的结果

Shoji, Satoshi; Shah, Nishant P; Shrader, Peter; Thomas, Laine E; Arnold, Jonathan D; Dhalwani, Nafeesa N; Thomas, Neena A; Kalich, Bethany; Priest, Elisa L; Syed, Mahanaz; Wójcik, Cezary; Peterson, Eric D; Navar, Ann Marie

Accelerating evidence generation to implementation: Establishment of the Leading Awareness to Action through Implementation of Cardiometabolic Efforts (LATTICE) consortium

加速证据生成并转化为实际行动:建立引领意识提升、通过实施心血管代谢举措实现行动的联盟(LATTICE)

Jones, Laney K; Gluckman, Ty J; Bhatt, Ankeet S; Boer, Leandro; Bonaca, Marc P; Campbell-Salome, Gemme; Davis, Erica; Desai, Nihar R; George, Jyothis; Head, Lisa; Marvel, Francoise A; Penn, Marc; Peterson, Eric D; Scirica, Benjamin M; Shah, Nishant P; Wilemon, Katherine; Kalich, Bethany A; Martin, Seth S

Insights from Patients and Physicians About Use of Evolocumab for LDL-C Management

来自患者和医生的关于使用依洛尤单抗治疗低密度脂蛋白胆固醇 (LDL-C) 的见解

Sidelnikov, Eduard; Jones, Laney K; Debrosse, Amalia; Okorozo, Peter; Kalich, Bethany

Distinct protein profiles in cord blood plasma of children with autism spectrum disorder

自闭症谱系障碍儿童脐带血浆中独特的蛋白质谱

Philosoph, Lital Kalich; Yoffe, Chen; El Biri, Bat; Baryakh, Polina; Saar, Efrat Glick; Mayorov, Margarita; Yosef, Omer Bar

Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events

PCSK9抑制剂单克隆抗体治疗启动时间与既往发生心血管事件患者的临床结局之间的关系

Sidelnikov, Eduard; Kalich, Bethany A; Miglins, Margot Lisa; Multani, Jasjit K; Tuly, Rifat; Hawkins, Kevin; Baber, Usman

Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization

药物到床位PCSK9抑制剂启动计划对接受ASCVD血运重建患者的LDL-C的影响

Lorenzatti, Daniel; Greenberg, Garred S; Filtz, Annalisa; Scotti, Andrea; Jaspan, Vita N; Park, Christine M; Kalich, Bethany; Jones, Laney K; Kathe, Niranjan; Di Palo, Katherine E; Browne, Constance; Lipsitz, Evan; Forest, Stephen J; Latib, Azeem; Garcia, Mario J; Rodriguez, Carlos J; Shapiro, Michael D; Gulati, Martha; Slipczuk, Leandro

LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy

LOGAN-CV:一项针对美国临床医生的多方面干预前瞻性研究,旨在改善基于指南的降脂治疗管理。

McKoy, J Nikki; Kalich, Bethany A; Greene, Laura; Mackey, Rachel H; Rosenthal, Ning A; Khan, Yosef; Wójcik, Cezary; Jones, Jenna; Carabuena, Leslie A

Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings

在真实世界环境中,PCSK9抑制剂单克隆抗体与依折麦布的持续性和依从性比较

Muntner, Paul; Ghazi, Lama; Jones, Jenna; Dhalwani, Nafeesa; Poudel, Bharat; Wen, Ying; Chen, Ligong; Wang, Zhixin; Bittner, Vera; Kalich, Bethany; Farkouh, Michael E; Woodward, Mark; Colantonio, Lisandro D; Rosenson, Robert S

Coronary Microvascular Dysfunction

冠状动脉微血管功能障碍

Sandoval, Yader; Cigarroa, Joaquin E; Dangas, George D; Lansky, Alexandra J; Naidu, Srihari S; Rao, Sunil V; Seto, Arnold H; Shah, Samit; Shroff, Adhir R; Toleva, Olga; Tremmel, Jennifer A; Riley, Robert F; Henry, Timothy D; Baumgard, Connie S; Bijoux, Ilka; Cavaliere, Lisa; Culbertson, Casey; Deible, Regina; El-Sabban, Maya; Jackson, Jeremy; Jackson, Melissa; Kalich, Bethany; Long, Vanessa; Newell, Amy; Perkins, Daya; Ramakrishnan, Krish; Russell, Karen; Sharma, Vinod; West, Nick E J; Whalen-Morton, Chrissy; Underwood, Paul; Winterfeldt, Kristi; Wojcik, Cezary; Zizzo, Steve

Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries

医疗保险受益人在心肌梗死住院后进行低密度脂蛋白胆固醇检测

Colantonio, Lisandro D; Wang, Zhixin; Jones, Jenna; Dhalwani, Nafeesa N; Shannon, Erin D; Liu, Cici; Kalich, Bethany A; Muntner, Paul; Rosenson, Robert S; Bittner, Vera